Clinical Trials Browser

imgatuzumab × Tumor-Agnostic × Clear all

NCT04985825 2022-09-13

I-PACE

Phase 2 Withdrawn

Carcinoma, Neoplasms

NCT00721266 2016-11-02

A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.

Phase 1 Completed

Neoplasms